MAPT and Alzheimer disease: NF-α1 gene delivery improved cognitive function and reduced amyloid plaques in AD mice. NF-α1 gene therapy promoted neurogenesis and improved hippocampal synaptic integrity. Significant reduction in tau hyperphosphorylation and neuroinflammation.